News
Watch our Facebook Session from January 25, where FBC’s Research and Education Team, Dr. Mary Sunderland and Dr. Chad Andrews, discussed four vision research and treatment trends to watch for in 2018!…
Read More about Four Vision Research and Treatment Trends to Watch in 2018 [Facebook Live] (Video)
With the December 2017 announcement that the world’s first ocular gene therapy had received approval by the U.S. Food and Drug Administration (FDA), there’s no doubt that 2017 was a landmark year…
Read More about Four Vision Research and Treatment Trends to Watch in 2018
Yesterday, we helped TMX Group close the market for the 20th Shorcan Charity Day! For the last 20 years, Shorcan Brokers Limited has donated one day’s profits to charities, including Fighting Blindness…
Read More about Shorcan Charity Day Raises $7,000 for Vision Research
Unless there is a research breakthrough very soon, Shelagh Anson’s children will lose their sight in their teens. Rowan and Caroline were born with Usher Syndrome, a disease that affects hearing and…
Read More about Racing Against the Clock
Today we are celebrating the FDA’s pathbreaking approval of Luxturna. We have been following the development of Luxturna closely. Today’s landmark FDA approval makes Luxturna the first gene therapy approved in the…
Read More about First gene therapy for a blinding eye disease receives FDA approval
In many retinal diseases, vision loss occurs when cells that are crucial for vision are damaged or lost. This is the case, for example, in age-related macular degeneration (AMD), retinitis pigmentosa, choroideremia,…
Read More about Survival of the Fittest: Sustaining Cells Through TransplantationJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
